SHARE: Change: 0.05 SEK / Bid: 9.95 SEK / Ask: 10.00 SEK / Price: 10.00 SEK / High: 10.00 SEK / Low: 9.60 SEK / Quantity: 5990 / Turnover: 59 577 SEK / 2017-09-18 22.00

The Projects – SpagoPix and Tumorad

Spago Nanomedical develops nanomedical products for diagnostics and treatment of cancer. Our main business focuses on two development projects: SpagoPix and Tumorad.

SpagoPix is a nanomedical contrast agent for magnetic resonance tomography (MRI). The goal is more precise visualization of tumors than what is possible today. With an early and correct tumor diagnosis, prerequisites for successful treatment are improved. Read more…

Tumorad enables for internal radiation therapy of tumors, so called radionuclide therapy. The tumor selectivity of Tumorad means that the radioactive substance will become accumulated to a larger extent in tumor tissue than in surrounding healthy tissue. Thereby, the cancer patient can be more efficiently treated, with fewer side effects and less negative impact on quality of life. Read more…